HPRA working at EU level to remove/reduce MI in cosmetics

News Category: Regulatory news

Date: 29/04/2015

The HPRA states that whilst the vast majority of consumers won’t have sensitivity to Methylisothiazolinone (MI) it is concerned about increased sensitivity to MI overall. The HPRA, in tandem with our colleagues across the other EU Member States, has been and is currently working with the European Commission on new laws to reduce the amount of MI permitted in cosmetic products.

HPRA Statement on Methylisothiazolinone

« Back